Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis wins US OK for biosimilar version of Amgen's Enbrel
Novartis wins US OK for biosimilar version of Amgen's Enbrel
Novartis wins US OK for biosimilar version of Amgen's Enbrel
Submitted by
admin
on August 31, 2016 - 9:27am
Source:
Yahoo/AP
News Tags:
Novartis
biosimilars
Amgen
Enbrel
rheumatoid arthritis
Erelzi
Headline:
Novartis wins US OK for biosimilar version of Amgen's Enbrel
Do Not Allow Advertisers to Use My Personal information
